Literature DB >> 19077694

Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease.

Julie R Ingelfinger1.   

Abstract

PURPOSE OF REVIEW: Angiotensin-converting enzyme 2 (ACE 2), the main product of which is Ang 1-7, which binds to its receptor, Mas, is an important member of the renin-angiotensin system. RECENT
FINDINGS: A substantial body of research indicates that ACE2 is cardioprotective and renoprotective. ACE2 participates in a pathway that is counterregulatory to the effects of angiotensin II (Ang II). The mechanisms by which the protective effects of ACE2 occur are just beginning to be elucidated.
SUMMARY: As ACE2 appears to exert protective effects within the kidney and vasculature, recent data indicate that how it is expressed, what regulates it, and how it interacts with other biological systems may ultimately have clinical implications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19077694     DOI: 10.1097/MNH.0b013e32831b70ad

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  28 in total

1.  High Na intake increases renal angiotensin II levels and reduces expression of the ACE2-AT(2)R-MasR axis in obese Zucker rats.

Authors:  Preethi Samuel; Quaisar Ali; Rifat Sabuhi; Yonnie Wu; Tahir Hussain
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-16

Review 2.  New pharmacological treatments for improving renal outcomes in diabetes.

Authors:  Anne-Emilie Declèves; Kumar Sharma
Journal:  Nat Rev Nephrol       Date:  2010-05-04       Impact factor: 28.314

Review 3.  Sex differences in vascular physiology and pathophysiology: estrogen and androgen signaling in health and disease.

Authors:  Austin C Boese; Seong C Kim; Ke-Jie Yin; Jean-Pyo Lee; Milton H Hamblin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-16       Impact factor: 4.733

4.  Angiotensin II type 1 receptor gene polymorphism and telomere shortening in essential hypertension.

Authors:  Wael Farrag; Manal Eid; Sherien El-Shazly; Manal Abdallah
Journal:  Mol Cell Biochem       Date:  2011-01-14       Impact factor: 3.396

5.  Maternal diabetes programs hypertension and kidney injury in offspring.

Authors:  Yun-Wen Chen; Isabelle Chenier; Stella Tran; Michael Scotcher; Shiao-Ying Chang; Shao-Ling Zhang
Journal:  Pediatr Nephrol       Date:  2010-04-27       Impact factor: 3.714

6.  Gene transfer of angiotensin-converting enzyme 2 in the nucleus tractus solitarius improves baroreceptor heart rate reflex in spontaneously hypertensive rats.

Authors:  Masanobu Yamazato; Anderson J Ferreira; Yoriko Yamazato; Carlos Diez-Freire; Lihui Yuan; Robert Gillies; Mohan K Raizada
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2011-06-30       Impact factor: 1.636

7.  Original Research: ACE2 activator associated with physical exercise potentiates the reduction of pulmonary fibrosis.

Authors:  Luana O Prata; Carolina R Rodrigues; Jéssica M Martins; Paula C Vasconcelos; Fabrício Marcus S Oliveira; Anderson J Ferreira; Maria da Glória Rodrigues-Machado; Marcelo V Caliari
Journal:  Exp Biol Med (Maywood)       Date:  2016-08-21

Review 8.  Angiotensin peptides and nitric oxide in cardiovascular disease.

Authors:  Kaushik P Patel; Harold D Schultz
Journal:  Antioxid Redox Signal       Date:  2012-05-21       Impact factor: 8.401

9.  Nrf2 Deficiency Upregulates Intrarenal Angiotensin-Converting Enzyme-2 and Angiotensin 1-7 Receptor Expression and Attenuates Hypertension and Nephropathy in Diabetic Mice.

Authors:  Shuiling Zhao; Anindya Ghosh; Chao-Sheng Lo; Isabelle Chenier; James W Scholey; Janos G Filep; Julie R Ingelfinger; Shao-Ling Zhang; John S D Chan
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

10.  Overexpression of catalase prevents hypertension and tubulointerstitial fibrosis and normalization of renal angiotensin-converting enzyme-2 expression in Akita mice.

Authors:  Yixuan Shi; Chao-Sheng Lo; Isabelle Chenier; Hasna Maachi; Janos G Filep; Julie R Ingelfinger; Shao-Ling Zhang; John S D Chan
Journal:  Am J Physiol Renal Physiol       Date:  2013-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.